The centerpiece of this annual contest involved promising early-career scientists proposing pioneering pilot studies aimed at deconstructing the complex biological and cognitive mechanisms underlying brain health across the lifespan. Finalists presented their research concepts in a dynamic, Shark Tank-style competition, where real-time audience voting determined grant recipients from a pool of high-caliber projects. This innovative format fosters a collaborative atmosphere, blending scientific rigor with interactive community engagement, thereby enhancing public investment in neuroscience research.

A key highlight of the 2025 awards was the Jennifer and Peter Roberts Visionary New Scientist Award, bestowed upon Anna Thompson. Her project focuses on elucidating the differential impacts of neurological cellular integrity on age-related brain changes, leveraging advanced neuroimaging and molecular biomarkers to map trajectories of neuronal health degradation. Thompson’s approach integrates functional and structural imaging modalities with cellular biochemistry to unravel the heterogeneity of aging processes in distinct neural substrates, potentially redefining early diagnostic criteria for cognitive decline.

Equally compelling was the Cindy and Charlie Feld Visionary New Scientist Award, granted to doctoral candidate Audrina Ebrahimi. Ebrahimi’s research converges on identifying biomarkers indicative of neurovascular health and their predictive power regarding cognitive functioning. By deploying longitudinal neuroimaging coupled with blood-based biomarker assays, her study aims to elucidate vascular contributions to dementia and other neurodegenerative conditions. This work signals a critical advancement toward multidisciplinary biomarker approaches, enhancing precision medicine strategies in neurology.

Maximilian Ciesla received the Maisie Heiken Visionary New Scientist Award for his investigation into adolescent brain development and its role in updating self-esteem based on social feedback. Situated within developmental social-affective neuroscience, his study employs cutting-edge functional MRI techniques to dissect neural circuitry associated with social cognition and emotional regulation during a critical period of plasticity. Through this lens, Ciesla’s work promises to inform early intervention protocols targeting mental health problems with roots in adolescent neurodevelopmental trajectories.

The Lyda Hill Philanthropies Visionary New Scientist Award honored Micaela Andreo for her project addressing nutrient delivery pathways in the brain — a hitherto underexplored axis in Alzheimer’s therapy. With a focus on neurovascular coupling and the blood-brain barrier, Andreo’s research leverages advanced neuropsychometric assessments combined with molecular analyses to identify therapeutic targets that could mitigate nutrient transport deficiencies in neurodegeneration. Having previously garnered the audience-choice award at the 2024 luncheon, Andreo’s continued exploration marks a significant contribution to translational Alzheimer’s research.

The contest also featured two additional finalists with promising proposals, underscoring the broad scientific scope of the event. Taesun Kim proposed an innovative study on adolescent self-compassion, investigating its neural and emotional correlates within a home-based intervention framework. This research aims to delineate the neurobiological underpinnings of self-compassion as a protective factor against mood disorders, employing neuroimaging and psychometric tools to validate intervention efficacy. Similarly, the team of Ashley Campos and Stephanie Rodriguez put forward a study titled “A Guiding Light to Mindfulness,” examining the role of mindfulness in mediating the transition from depression to resilience. Their multidisciplinary approach integrates theoretical frameworks from clinical psychology with neurophysiological measurements to unveil mechanisms through which mindfulness catalyzes neurocognitive adaptation.

The 2025 luncheon was particularly poignant as it highlighted the sustained generosity of Ramona Jones and her family, marking their third consecutive year of sponsorship. The celebration intertwined philanthropic commitment with a tribute to the power of lifestyle factors in promoting longevity and brain health. As Sandi Chapman, PhD, the Founder and Chief Director of BrainHealth, poignantly remarked, Jones embodies the “poster girl” for brain health, illustrating the profound effects of a brain-healthy lifestyle on life span and quality of cognitive function.

Moderating the event was Dan Krawczyk, PhD, Deputy Director of Research at BrainHealth, who facilitated panel discussions that bridged scientific discourse with public understanding. The event also attracted high-profile members of UT Dallas’s administration, including Adam J. Woods, PhD, Dean of the School of Behavioral and Brain Sciences, and several Vice Presidents, signifying institutional commitment to advancing brain health research and innovation.

The Center for BrainHealth at UT Dallas, the event’s host institution, is a translational research powerhouse devoted to enhancing, preserving, and restoring cognitive function through cutting-edge neurobiological research and innovative therapeutics. Employing advanced functional and structural neuroimaging techniques, the Center elucidates the intricate neurobiology of cognition and emotion under both health and disease conditions. The translation of findings into practical brain performance strategies empowers individuals across the lifespan to harness cognitive potential and resilience.

Central to the Center’s approach is the BrainHealth Index, a proprietary metric uniquely capable of quantifying an individual’s holistic brain health trajectory. This innovative tool integrates multi-dimensional data to chart cognitive trends objectively and longitudinally, allowing researchers and clinicians to detect declines or improvements with precision. Complementing this is the Strategic Memory Advanced Reasoning Tactics (SMART™) program, a scientifically validated methodology designed to optimize cognitive strategies. Over three decades of rigorous research underpin this strategy-based training, which empowers participants to enhance memory, reasoning, and overall executive function.

The Ramona Jones Friends of BrainHealth Luncheon serves as a microcosm of the innovative frontier in brain science, demonstrating how collaborative investments in early career scientists can catalyze breakthroughs with far-reaching implications. From understanding the cellular substrates of aging and neurovascular health to leveraging cognitive and emotional interventions in adolescence and neurodegenerative diseases, the awarded studies embody a multi-faceted attack on some of neuroscience’s most pressing challenges. Through such community-engaged platforms, the future of brain health research continues to unfold with promise and vigor.

Subject of Research: Advances in brain health research focusing on neurobiology, cognitive aging, neurovascular biomarkers, adolescent brain development, Alzheimer’s disease, mindfulness, and emotional regulation interventions.

Article Title: Ramona Jones Friends of BrainHealth Luncheon Catalyzes Next-Generation Brain Science Innovation

News Publication Date: September 29, 2025

Web References:

• Center for BrainHealth: https://centerforbrainhealth.org/
• BrainHealth Index: https://centerforbrainhealth.org/science/brainhealth-index
• SMART™ Program: https://centerforbrainhealth.org/training/smart

Image Credits: Center for BrainHealth

Traditional health AI systems have largely been designed within rigid binary gender models, frequently neglecting the unique physiological and psychosocial needs of transgender and non-binary populations. Such limitations not only restrict the utility of AI-powered healthcare tools for these communities but also risk exacerbating existing health disparities. The recent study delves into these concerns by engaging members of the transgender community directly in its research process, embracing a communicative methodology that emphasizes participatory collaboration rather than top-down analysis. This approach marks an essential shift in biomedical AI research, highlighting the importance of involving marginalized groups to co-create more equitable technologies.

The research was conducted in close partnership with the LGBTQIA+ advocacy group PRISMA, which plays a pivotal role in defending the rights of sexual and gender minorities within scientific and technological innovation spheres. This collaboration ensured that the study remained grounded in real-world experiences and ethical imperatives, avoiding the common pitfall of tokenistic inclusion. Representatives from the Health Care and Promotion Service for Trans and Non-Binary People (TRÀNSIT) at the Catalan Health Institute also provided critical insights, further enriching the study’s contextual relevance and fostering trust between researchers and participants.

At the heart of the study were three telematic focus groups composed of eighteen transgender individuals tasked with articulating their experiences and perspectives concerning current AI applications in healthcare. Participants reported that many existing AI tools propagate the biases of their predominantly cisgender developers. As an illustrative example, certain voice modification applications, designed to assist in gender transition, frequently misclassify users by gender. This misrecognition not only undermines the app’s therapeutic efficacy but also inflicts emotional distress on users by invalidating their gender identity through technology.

Such technological missteps are emblematic of a larger problem: the replication and amplification of societal biases within AI systems. This pernicious feedback loop leads to the invisibilization of transgender people, reinforcing structural inequities. Simón Perera del Rosario, a co-author from UPF, highlighted that this dynamic can have deleterious effects on mental health, self-esteem, and overall quality of life for transgender individuals. These findings emphasize the ethical imperative to design AI systems that are not just functionally effective but also socially responsible.

One of the study’s major recommendations focuses on leveraging AI’s capabilities to enhance the personalization of medical treatments, notably in the administration of masculinizing or feminizing hormonal therapies. Currently, hormone dosages are often standardized according to cisgender parameters, ignoring the distinct physiological profiles within transgender populations. AI systems, equipped with diverse data reflecting individual variations, could optimize dosage regimens and monitor potential interactions with other medications, thus minimizing side effects and maximizing therapeutic outcomes. This precision medicine approach marks a significant advance toward truly individualized care.

Participants also stressed the crucial importance of ethical data management. Their concerns revolve around how personal data related to gender identity is collected, stored, and used within medical systems. The group advocated for strictly limiting the use of such sensitive data to relevant medical contexts, entrusting only qualified health professionals with this information. This precaution is vital to prevent unauthorized misuse and to respect privacy, which has historically been a major barrier for transgender individuals seeking care. Furthermore, participants warned that AI systems built on binary frameworks risk misinterpreting data, thereby leading to diagnostic inaccuracies or inappropriate treatment decisions.

The mistrust of healthcare institutions among many transgender individuals is a significant hurdle that technology alone cannot overcome. This distrust stems from a long history of discrimination and medical pathologization, underscored by the World Health Organization’s delayed removal of “transsexuality” as a mental disorder only in 2019. To rebuild trust, the study underscores the necessity for comprehensive healthcare professional education and sensitization to transgender-specific health needs. Such training initiatives would enhance provider competence and foster more respectful, informed patient interactions, which are essential for effective AI integration in clinical practice.

Expanding the scientific evidence base concerning transgender health and AI is another vital pillar of the study’s agenda. Current research addressing these intersecting domains remains alarmingly sparse. There is an urgent need for more scholarly attention focused on developing AI models that reflect gender diversity holistically, from data collection to algorithmic design and deployment. Encouraging interdisciplinary collaboration among computer scientists, clinicians, and social scientists will be critical to ensuring these models are robust, ethical, and clinically impactful.

Moreover, fostering solidarity networks and knowledge exchange platforms between transgender communities and healthcare professionals holds great promise. These spaces enable the co-creation of AI tools grounded in lived experience, thereby enhancing relevance and acceptance. By engaging stakeholders throughout AI development cycles, the healthcare field can produce technologies that empower rather than alienate marginalized groups.

The study’s communication methodology itself represents an innovative research paradigm that upends conventional investigator-led approaches. By actively involving transgender participants in the research design and oversight, facilitated by PRISMA, the research ensured that ethical standards were meticulously upheld and that outcomes would resonate authentically with the community. This participatory ethic exemplifies a progressive direction for AI research writ large, emphasizing inclusivity, transparency, and reciprocal respect.

In conclusion, the ongoing evolution of AI in healthcare offers unprecedented opportunities to deliver personalized, equitable medical care. However, realizing this potential necessitates deliberate efforts to dismantle ingrained binary biases in AI systems. The interdisciplinary collaboration between UPF, BSC-CNS, URV, and advocacy partners like PRISMA points the way toward constructing AI applications that truly reflect and serve the diverse tapestry of human gender identities. Embracing this vision promises not only to improve health outcomes for transgender individuals but also to enrich the field of AI-powered medicine as a whole with more nuanced, just, and humane technologies.

Subject of Research: People

Article Title: Exploring Gender Bias in AI for Personalized Medicine: Focus Group Study With Trans Community Members

News Publication Date: 29-Jul-2025

Web References:

• Journal of Medical Internet Research DOI link
• PRISMA association
• TRÀNSIT Health Care and Promotion Service

References: None declared.

Keywords:
Artificial intelligence, Personalized medicine, Algorithms, Transgender identity

The ASU-Science Prize for Transformational Research represents a bold step towards emphasizing the societal relevance of scientific inquiry. By partnering with Science, AAAS’s flagship peer-reviewed journal, the prize acknowledges the urgent need for research that explicitly addresses complex real-world problems through novel methodologies. The scope of eligible research is broad, encompassing fields that directly inform challenges such as public health crises, environmental sustainability, and the deployment of artificial intelligence technologies in ethical and beneficial ways.

Sally C. Morton, Executive Vice President of ASU’s Knowledge Enterprise, articulated the vision behind the prize, highlighting the imperative to empower upcoming scientific leaders in creating tangible societal benefits. Morton emphasized that the future trajectory of science must be rooted in intentional community engagement and interdisciplinary collaboration to foster a thriving society and sustainable planet. This reflects a paradigm shift in scientific priorities, where impact and translational value are considered as paramount as methodological rigor and discovery.

The modern scientific enterprise increasingly recognizes that isolated theoretical advancement is insufficient to address the systemic and multifaceted nature of today’s global challenges. Researchers are called upon to design, execute, and communicate their work with an acute awareness of societal contexts and implications. The ASU-Science Prize formalizes this expectation by specifically rewarding early-career investigators who integrate social considerations into the fabric of their research frameworks and dissemination strategies.

Valda Vinson, Executive Editor at Science, reinforced the importance of this initiative, underscoring the journal’s commitment to facilitating scholarly contributions that resonate beyond academia. “We seek to recognize work that can help tackle difficult problems we face at scale,” Vinson stated, highlighting the dual role of academic institutions and scientific journals as catalysts for impactful discovery. The prize thereby becomes not only a form of recognition but also a platform to elevate transformative work to the global stage.

Applicants for the prize are invited from all scientific disciplines, reflecting an understanding that societal impact transcends conventional disciplinary silos. Entrants must submit a detailed essay articulating their most significant research findings, with an emphasis on how these discoveries are poised to generate meaningful social change. This narrative component invites researchers to reflect critically on the intersection of science and society, encouraging clear communication that bridges academic and public audiences.

The grand prize winner’s essay will be published in Science, providing unprecedented visibility and validation. Alongside this honor, the recipient will receive a monetary award of USD 30,000, underscoring the tangible support offered to promising scientists at pivotal moments in their careers. The combination of publication and funding aims to stimulate continued innovation and signal the high value placed on research that advances collective well-being.

The submission deadline is August 15, underscoring a swift timeline for early-career researchers eager to participate. Detailed application instructions are accessible via the Science website, ensuring transparency and facilitating broad accessibility. The initiative’s timing and structure stress the urgency and priority of socially engaged science, calling upon a new generation of scholars to reorient the research landscape toward transformative outcomes.

Arizona State University, long recognized for its pioneering approach to higher education, underscores the prize’s foundational ethos. Ranked consecutively as the nation’s No. 1 “Most Innovative School” by U.S. News & World Report for a decade, ASU embodies a model of a New American University that values innovation, interdisciplinarity, and accessibility. The institution’s emphasis on personalized learning and actionable research aligns seamlessly with the goals of the ASU-Science Prize.

For the broader scientific community, this prize signals a critical affirmation that the impact of research is measured not solely by scholarly citations but by the degree to which science actively shapes policy, drives societal progress, and addresses pressing challenges at scale. It encourages a culture shift where early-career scientists aspire not only to excel in their fields but also to become agents of positive transformation on a global level.

In summary, the ASU-Science Prize for Transformational Research stands as a pivotal development in contemporary science policy. It acknowledges the complex, interdisciplinary nature of today’s scientific challenges and rewards early-career investigators who rise to meet them with creativity, rigor, and social consciousness. As applicants prepare their submissions, the scientific world watches with anticipation, hopeful that this initiative will cultivate breakthroughs that enrich both knowledge and society.

Subject of Research: Not specified in detail; broadly focuses on early-career scientific research with societal impact spanning fields such as public health, policy, and artificial intelligence.

Article Title: Not provided.

News Publication Date: Not explicitly stated; referred to as announced in January with submissions opening May 1 and deadline August 15 of the current year.

Web References:

• https://www.aaas.org/news/aaas-asu-collaborative
• https://www.science.org/content/page/asu-science-prize-transformational-impact

References: Not provided.

Image Credits: Not provided.

Keywords: Science policy, Scientific community